ABSTRACT
Background and Purpose Common sequelae for patients with congenital heart disease (CHD) are neurodevelopmental disabilities including executive function, attention, and socio-emotional deficits. Although these are common diagnoses for patients with CHD, limited research has investigated the mechanistic underpinnings of these findings. Our previous research examined the association between abnormal respiratory ciliary motion and brain abnormalities in infants with CHD. Results suggested that abnormal ciliary motion correlated to a spectrum of subtle dysplasia, notably within the olfactory bulb (OB)1. Our current study investigates whether OB anomalies predict neurodevelopmental outcomes for pediatric patients with CHD. We hypothesize that adolescents with CHD who exhibit aberrant morphological measurements in the OB are more likely to suffer from executive functional deficits.
Materials and Methods A prospective, observational study of 54 CHD and 75 healthy subjects, ages 6-25 years old, was completed under the supervision of a senior pediatric neuroradiologist. T2 3D Space and T2 Blade 2MM MRI images were manually segmented to extract volumetric bilateral regions of the OB and cerebrospinal fluid (CSF) using ITK-SNAP. Imaging metrics were correlated to OB asymmetry, CSF to OB ratio, total CSF volume, total OB volume, and independent left and right CSF and OB volumes. Linear regression was used to evaluate MRI morphologic measurements with co-variates: CHD status, sex, MRI age, and segmenter. Executive function was determined by the Behavioral Rating Inventory of Executive Function (BRIEF) Parent Report and Delis-Kaplan Executive Function System (D-KEFS) for subjects ages 6-16. Cognition and olfactory function were measured with the NIH Toolbox Cognitive Battery and Odor Identification Test, respectively.
Results No statistically significant results were reported between cohorts for asymmetry of OB, CSF to OB ratio, total CSF volume, total OB volume, nor between independent left and right CSF and OB volumes. Increased OB volume was associated with worse outcomes on the BRIEF Parent Report (p≤0.03). Asymmetry of OB predicted poorer executive functioning as reported by parents on the BRIEF (p≤0.05). Overall, the CHD cohort demonstrated worse scores on the BRIEF Parent Report compared to controls. Across groups, no significant association was reported for olfaction function measured by the NIH Toolbox Odor Identification Test on a limited subset of participants.
Conclusion As survival rates for CHD improve, there is an increased risk of long-term neurodevelopmental impairments. Our findings identify adolescents who are at risk for executive dysfunction, particularly those showing increased OB volume and/or asymmetry of the OB. This is particularly concerning for the CHD population with atypical OB morphology, who also exhibit significantly poorer outcomes on the BRIEF Parent Report and face a higher overall risk. Increased OB volume and OB asymmetry are olfactory-based biomarkers that may help identify at-risk CHD patients earlier, enabling more timely intervention and support.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Department of Defense (W81XWH-16-1-0613), the National Institutes of Health, National Heart, Lung and Blood Institute (R01 HL152740-1, R01 HL128818-05, and F31 HL165730-02), the National Heart, Lung and Blood Institute with National Institute of Aging (R01 HL128818 and R01 HL128818-S1), the National Center for Advancing Translational Sciences (UL1TR001857) and Additional Ventures.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study describes the use of human data and involves human subjects; therefore, a decision from the Institutional Review Board for approval was required. All ethical guidelines have been followed, and necessary Institutional Review Board approvals have been obtained. Datasets were used only after formal Institutional Review Board approval. No simulated data or data openly available to the public was used before the initiation of the study. The Institutional Review Board of the University of Pittsburgh gave ethical approval for this work. The Institutional Review Board STUDY20060128: Multimodal Connectome Study approval 14 May 2014 and STUDY1904003 Ciliary Dysfunction, Brain Dysplasia, and Neurodevelopmental Outcome in Congenital approval 10 August 2016. The project was completed in accordance with the ethical principles of the Helsinki Declaration. Written informed consent was obtained from all participants, including consent from parents/guardians (including consent to publish), and the appropriate institutional forms have been archived. Any patient identifiers included were not known to anyone outside of the research group so cannot be used to identify individuals.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices), Study Protocol, and Statistical Analysis Plan, are available upon formal request. Requests should be submitted to the corresponding author.
Abbreviations
- CHD
- congenital heart disease
- OB
- olfactory bulb
- CSF
- cerebrospinal fluid
- BRIEF
- Behavioral Rating Inventory of Executive Function
- D-KEFS
- Delis-Kaplan Executive Function System